Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

1.9K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K
Clinical Trials01:16

Clinical Trials

11.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.1K
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

388
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
388
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient and staff experiences of a community-based diagnostic clinic for chronic eye conditions: Qualitative analysis.

Eye (London, England)·2026
Same author

Adaptation to San Martín Quechua and psychometric analysis of the Patient Health Questionnaire (PHQ-9) in Peruvian adults.

BMC psychology·2026
Same author

Continuation and discontinuation of antidepressant treatment before, during and after pregnancy: a cohort study.

Archives of women's mental health·2026
Same author

Interventions That Use Highly Visual Social Media Platforms to Tackle Unhealthy Body Image in Adolescents and Young Adults: Systematic Review of Randomized Controlled Trials and Quasi-Experimental Studies.

Journal of medical Internet research·2026
Same author

Annual prevalence of the body mass index documentation in the UK primary care: A cross-sectional study using IQVIA medical research data.

Diabetes, obesity & metabolism·2025
Same author

Mind the Gaps: Literature Survey Reveals Shortcomings in Handling Missing Data in Clinical Practice Research Datalink (CPRD), a UK Primary Care Health Records Database.

Clinical epidemiology·2025
Same journal

Stress Disorders and Human Papillomavirus-Related Cancer Rates: A Population-Based Cohort Study in Denmark.

Clinical epidemiology·2026
Same journal

Making Statistics Clinically Meaningful.

Clinical epidemiology·2026
Same journal

Sensitivity of Administrative Coding for Heart Disease in Pregnancy.

Clinical epidemiology·2026
Same journal

Cohort Profile: The Central Denmark Cancer Cohort.

Clinical epidemiology·2026
Same journal

The Danish Database for Hepatitis B and C (DANHEP): A Nationwide, Prospective, Ongoing Cohort Study.

Clinical epidemiology·2026
Same journal

Pregnancy Outcomes in Women with Type 1 Diabetes by Socioeconomic and Mental Health Disadvantages.

Clinical epidemiology·2026
See all related articles

Related Experiment Video

Updated: Mar 31, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K

Data Resource Profile: IQVIA Medical Research Data (IMRD).

Holly Christina Smith1, Juan Carlos Bazo-Alvarez1, Louise Pinder2

  • 1Department of Primary Care and Population Health, University College London, London, UK.

Clinical Epidemiology
|March 30, 2026
PubMed
Summary
This summary is machine-generated.

IQVIA Medical Research Data (IMRD) offers longitudinal, anonymized primary care data for over 6 million English patients. This valuable resource supports research into diseases, treatments, and patient outcomes to enhance healthcare decisions.

Keywords:
data resource profileelectronic health recordsepidemiologyprimary care

More Related Videos

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.8K
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.8K

Related Experiment Videos

Last Updated: Mar 31, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K
The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.8K
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.8K

Area of Science:

  • Health Informatics
  • Epidemiology
  • Health Services Research

Background:

  • The IQVIA Medical Research Data (IMRD) is a comprehensive dataset designed for population-based research.
  • It aims to provide insights into primary care, informing healthcare decisions and improving patient outcomes.

Purpose of the Study:

  • To detail the scope and utility of the IMRD for various research applications.
  • To highlight the data's potential for understanding disease burden, treatment patterns, drug safety, and health economics.

Main Methods:

  • Utilizes longitudinal, anonymized data from primary care practices in England.
  • Includes data on over 6 million individuals, with 2.2 million actively contributing as of January 2024.
  • Covers patient characteristics, clinical events, medications, tests, and health information.

Main Results:

  • IMRD contains detailed information on primary care consultations and patient health journeys.
  • Offers a median of 8 years of follow-up data, with both historic and current records available.
  • The dataset has NHS Research Authority approval for medical research.

Conclusions:

  • IMRD is a robust resource for diverse health research, including outcomes research and health economics.
  • Access is governed by strict protocols, ensuring scientific merit and potential benefit to health and social care.
  • Facilitates external researcher access via Data Sharing Agreements for approved studies.